Agenus to Participate in B. Riley Healthcare Conference
04 Janeiro 2024 - 9:30AM
Business Wire
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering
and developing novel immunological agents to treat various cancers,
today announced that Dr. Garo Armen, Chairman and CEO, will
participate in a fireside chat and investor one-on-ones at the
upcoming B. Riley Virtual Healthcare Conference on January 18th.
The fireside chat will take place at 3:00 p.m. ET on January
18th.
To access this event, please RSVP to your B. Riley Securities
sales representative. Following the event, a replay of the fireside
chat will be posted to the company’s website at
https://investor.agenusbio.com/events-and-presentations.
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and
infectious diseases with a comprehensive pipeline of immunological
agents. The company’s mission is to expand patient populations
benefiting from cancer immunotherapy through combination
approaches, using a broad repertoire of antibody therapeutics,
adoptive cell therapies (through MiNK Therapeutics) and adjuvants
(through SaponiQx). Agenus is headquartered in Lexington, MA. For
more information, visit www.agenusbio.com or @agenus_bio.
Information that may be important to investors will be routinely
posted on our website and social media channels.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240104722958/en/
Investor Contact
917-362-1370 investor@agenusbio.com
Media Contact 781-674-4784
communications@agenusbio.com
Agenus (NASDAQ:AGEN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Agenus (NASDAQ:AGEN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024